NCT01621802 - Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age | Biotech Hunter

Enrollment

4,011

Participants

Timeline

Start Date

June 21, 2012

Primary Completion Date

July 6, 2015

Study Completion Date

November 9, 2015

Conditions

Measles-Mumps-Rubella

Interventions

BIOLOGICAL

Priorix

One dose administered subcutaneously in the triceps region of the right arm.

BIOLOGICAL

M-M-R II

One dose administered subcutaneously in the triceps region of the right arm.

BIOLOGICAL

Kinrix

One dose administered by deep intramuscular injection in the upper left deltoid.

BIOLOGICAL

ProQuad

One dose administered subcutaneously in the triceps region of the left arm.

Trial Locations (67)

100

GSK Investigational Site, Taipei

104

GSK Investigational Site, Taipei

220

GSK Investigational Site, New Taipei City

333

GSK Investigational Site, Taoyuan District

404

GSK Investigational Site, Taichung

10467

GSK Investigational Site, The Bronx

16505

GSK Investigational Site, Erie

21045

GSK Investigational Site, Columbia

22015

GSK Investigational Site, Burke

22902

GSK Investigational Site, Charlottesville

25701

GSK Investigational Site, Huntington

27203

GSK Investigational Site, Asheboro

27609

GSK Investigational Site, Raleigh

29414

GSK Investigational Site, Charleston

29520

GSK Investigational Site, Cheraw

30062

GSK Investigational Site, Marietta

30189

GSK Investigational Site, Woodstock

32701

GSK Investigational Site, Altamonte Springs

35205

GSK Investigational Site, Birmingham

40004

GSK Investigational Site, Bardstown

44121

GSK Investigational Site, Cleveland

45245

GSK Investigational Site, Cincinnati

45406

GSK Investigational Site, Dayton

45414

GSK Investigational Site, Dayton

46256

GSK Investigational Site, Indianapolis

53566

GSK Investigational Site, Monroe

57701

GSK Investigational Site, Rapid City

67010

GSK Investigational Site, Augusta

67114

GSK Investigational Site, Newton

72019

GSK Investigational Site, Benton

72205

GSK Investigational Site, Little Rock

72703

GSK Investigational Site, Fayetteville

77055

GSK Investigational Site, Houston

77375

GSK Investigational Site, Tomball

80922

GSK Investigational Site, Colorado Springs

83686

GSK Investigational Site, Nampa

84095

GSK Investigational Site, South Jordan

84109

GSK Investigational Site, Salt Lake City

84604

GSK Investigational Site, Provo

84790

GSK Investigational Site, St. George

85704

GSK Investigational Site, Tucson

85741

GSK Investigational Site, Tucson

91706

GSK Investigational Site, Baldwin Park

92804

GSK Investigational Site, Anaheim

93726

GSK Investigational Site, Fresno

94015

GSK Investigational Site, Daly City

94545

GSK Investigational Site, Hayward

94588

GSK Investigational Site, Pleasanton

94596

GSK Investigational Site, Walnut Creek

94611

GSK Investigational Site, Oakland

95051

GSK Investigational Site, Santa Clara

95815

GSK Investigational Site, Sacramento

95823

GSK Investigational Site, Sacramento

97030

GSK Investigational Site, Gresham

561712

GSK Investigational Site, Jeollabukdo

02721

GSK Investigational Site, Fall River

425-707

GSK Investigational Site, Ansan

700-712

GSK Investigational Site, Daegu

301-723

GSK Investigational Site, Daejeon

431-070

GSK Investigational Site, Gyeonggi-do

641-560

GSK Investigational Site, GyeongSangNam-do

570-711

GSK Investigational Site, Iksan

120-752

GSK Investigational Site, Seoul

130-702

GSK Investigational Site, Seoul

139-706

GSK Investigational Site, Seoul

158-710

GSK Investigational Site, Seoul

220-701

GSK Investigational Site, Wonju-si Kangwon-do